Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00111982 | Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin | PHASE1 | COMPLETED | 34 | — | — | Dec 1, 2003 | Feb 1, 2006 | Feb 26, 2010 | - | — |
| Arm | Type | Description |
|---|---|---|
| Liatermin | EXPERIMENTAL | Bilateral continuous infusion of liatermin for up to 24 months. |
| Name | Type | Description |
|---|---|---|
| Liatermin | BIOLOGICAL | Liatermin |
Inclusion Criteria: - Completion of the 20020168 protocol